15 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
approval and may have a material adverse effect on its business.
Elicio or its CMOs may also encounter shortages in the raw materials or substances … by the purchase of such materials by its competitors or others. Elicio’s or its third-party manufacturers’ failure to obtain the raw materials
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
a material adverse effect on its business.
Elicio or its CMOs may also encounter shortages in the raw materials or substances necessary to produce its … of such materials by its competitors or others. Elicio’s or its third-party manufacturers’ failure to obtain the raw materials or substances necessary
S-4/A
x0trtkxyx8y09pr 6us
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-K
40z6i85slit gf
30 Mar 21
Annual report
5:00pm
424B4
8exuuhgmmjipd5
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
gx9lxmn3gcaw d0uym
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
6rkkt5re04h0ne
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next